New AI regulation in the EU seeks to reduce risk without assessing public benefit

Barbara Prainsack,Nikolaus Forgó
DOI: https://doi.org/10.1038/s41591-024-02874-2
IF: 82.9
2024-03-19
Nature Medicine
Abstract:The European Union's new AI Act focuses on risk without considering benefits, which could hinder the development of new technology while failing to protect the public.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?